The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference28 articles.
1. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis;BH Hahn;Arthritis Care Res (Hoboken),2012
2. The efficacy and safety of leflunomide therapy in lupus nephritis by repeat kidney biopsy;FS Zhang;Rheumatol Int,2009
3. Efficacy and safety of rituximab therapy for systemic lupus erythematosus: a systematic review and meta-analysis;L Lan;J Zhejiang Univ Sci B,2012
4. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide;FA Houssiau;Arthritis Rheum,2002
5. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients;M Ishaq;Mod Rheumatol,2011
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunosuppressive drug therapy;Dubois' Lupus Erythematosus and Related Syndromes;2025
2. Management of lupus nephritis;Dubois' Lupus Erythematosus and Related Syndromes;2025
3. II Brazilian Society of Rheumatology consensus for lupus nephritis diagnosis and treatment;Advances in Rheumatology;2024-06-18
4. A Comprehensive and Practical Approach to the Management of Lupus Nephritis in the Current Era;Advances in Kidney Disease and Health;2024-05
5. Comorbilidades en la esclerosis múltiple y su influencia en la elección del tratamiento;Revista de Neurología;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3